Lupin is recalling 16,056 bottles of Rifampin capsules, used in treatment of all forms of tuberculosis, in the US market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA). The affected lot has been produced at Lupin's Aurangabad plant and marketed in the US by Lupin's Baltimore-based arm Lupin Pharmaceuticals.